Table 2 Bivariate Associations with Anti-Platelet Use in Adults with Diabetes
From: Prevalence of antiplatelet therapy in patients with diabetes
Characteristic | Odds Ratio [95% CI] | P Value |
|---|---|---|
Male sex | 2.0 [1.5, 2.7] | <0.001 |
Age > 65 years | 2.0 [1.5, 2.6] | <0.001 |
Race/ethnicity, White, non-Hispanic | 2.0 [0.8, 5.2] | 0.15 |
Education: > HS graduate | 0.8 [0.6, 1.1] | 0.25 |
Married or living as married | 1.0 [0.8, 1.4] | 0.84 |
Smoker | 0.8 [.05, 1.1] | 0.16 |
Endocrinology consult within 1 year | 1.8 [1.2, 2.7] | 0.004 |
Diabetes education class within 1 year | 1.4 [1.0, 2.0] | 0.06 |
Insurance category | ||
None | 0.28 [0.10, 0.78] | 0.02 |
Private | 1.15 [0.86, 1.53] | 0.35 |
Medicare | 1.88 [1.40, 2.51] | <0.001 |
Medicaid | 0.98 [0.68, 1.4] | 0.91 |
Military | 1.78 [0.85, 3.70] | 0.13 |
Income < $30,000 | 1.1 [0.8, 1.5] | 0.55 |
Prescription coverage | 0.9 [0.7, 1.1] | 0.19 |
Body Mass Index | ||
BMI category (normal, overweight, obese) | 0.8 [0.7, 1.0] | 0.11 |
Obese (BMI > 30) | 0.8 [0.6, 1.0] | 0.07 |
Severe Obesity (BMI > 40) | 0.6 [.04, 0.9] | 0.01 |
Type of Cardiovascular Disease | ||
Any CVD | 3.3 [2.4, 4.3] | <0.001 |
Myocardial Infarction | 6.7 [4.0, 11.3] | <0.001 |
Stroke | 2.1 [1.2, 3.5] | 0.008 |
Peripheral Vascular Disease | 3.1 [1.7, 5.8] | <0.001 |
Number of PCP visits in previous month | 1.04 [0.97, 1.11] | 0.26 |
Duration of diabetes (in years) | 1.01 [1.00, 1.03] | 0.13 |